The New England Journal of Medicine

Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B

Prophylactic treatment for hemophilia B necessitates lifelong, regular intravenous factor IX infusions. Gene therapy offers the possibility of a single-dose treatment that produces durable endogenous ...
Open Heart

Sex differences in risk factor control and medication adherence post-ACS: insights from the TEXTMEDS randomised clinical trial

Introduction Poor adherence to risk factor control and life-saving medications is a key factor affecting long-term patient ...

Study builds a seven-factor scale of play, based on children's own words

If you need good play to have a good childhood, then we need to know what good play looks like. But studies of play often start from an adult perspective, leaving out kids' perspectives. To overcome ...
ascopubs.org

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized ...